title: [Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ].
abstract: Monoclonal gammopathy of undetermined significance (MGUS) are very frequent in the elderly. Its incidence is about 3% after 70 years. We have performed a retrospective study of patients aged of more than 70 years who were examined until 1995 for a MGUS.
  
  
  METHODS
  The study included 51 patients: 24 men and 27 women. Information about evolution was obtained by medical file or by asking medical practitioner. We know the evolution of all patients until January 1st 2000. The median follow-up is 5.8 years (70 months).
  
  
  RESULTS
  The MGUS remained stable for 34 patients (67%) with a median follow-up of 83 months (12 to 180 months). Nine patients (17%) developed malignant transformation of MGUS (6 multiple myeloma, 2 Waldenström macroglobulinemia, 1 malignant lymphoma). Eight (15%) developed a cancer. Twelve died without evidence of multiple myeloma or related disorder. The actuarial probability of malignant transformation at 5 years was 12%.
  
  
  CONCLUSIONS
  The risk of malignant transformation of MGUS doesn't decrease in the elderly. A regular and prolonged follow-up is necessary.
authors.affiliation: Département de médecine de l'adulte, hôpital Sud, 16, boulevard de Bulgarie, 35056 Rennes, France. olivdecaux@wanadoo.fr
authors.forename: O
authors.initials: O
authors.lastname: Decaux
authors.forename: C
authors.initials: C
authors.lastname: Cazalets-Lacoste
authors.forename: B
authors.initials: B
authors.lastname: Cador-Rousseau
authors.forename: E
authors.initials: E
authors.lastname: Laurat
authors.forename: M
authors.initials: M
authors.lastname: Sebillot
authors.forename: J
authors.initials: J
authors.lastname: Bracq
authors.forename: P
authors.initials: P
authors.lastname: Jego
authors.forename: R
authors.initials: R
authors.lastname: Leblay
authors.forename: B
authors.initials: B
authors.lastname: Grosbois
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008223:Lymphoma / Q000209:etiology; D008297:Male; D009101:Multiple Myeloma / Q000209:etiology; D010265:Paraproteinemias / Q000150:complications; D012189:Retrospective Studies; D008258:Waldenstrom Macroglobulinemia / Q000209:etiology
chemical_list: D007070:Immunoglobulin A; D007074:Immunoglobulin G